Psychopharmacology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.3 | Q2 | 67.6% | 1.147 | Q1 | 87.1% |
| 2024 | 3.3 | Q2 | 70.5% | 1.157 | Q1 | 87.6% |
| 2023 | 3.5 | Q2 | 71.7% | 1.053 | Q1 | 86.8% |
| 2022 | 3.4 | Q2 | 62.6% | 1.050 | Q1 | 87.3% |
| 2021 | 4.4 | Q2 | 69.8% | 1.103 | Q1 | 88.4% |
| 2020 | — | — | 1.378 | Q1 | 91.2% | |
| 2019 | — | — | 1.253 | Q1 | 90.0% | |
| 2018 | — | — | 1.395 | Q1 | 90.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1432-2072
ISSN
0033-3158
country
DEcoverage
1959-2026